UNIVERSITY OF VIRGINIA HEALTH SYSTEM IMAGE: IMRE NOTH, MD, THE CHIEF OF UVA HEALTH’S DIVISION OF PULMONARY AND CRITICAL CARE MEDICINE, SAYS THE LARGE STUDY OF IDIOPATHIC PULMONARY FIBROSIS WILL STILL BENEFIT EFFORTS TO BATTLE THE LUNG-SCARRING DISEASE. CREDIT: UVA HEALTH Doctors have hoped that antibiotics could benefit patients with chronic lung diseases, but a...
